Back to News
investment

Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Elite Pharmaceuticals held its Q3 2026 earnings call on February 18, led by CEO Nasrat Hakim and CFO Carter Ward, outlining financial performance and strategic updates. CEO Hakim emphasized forward-looking statements, noting potential risks and uncertainties under SEC safe harbor provisions, urging investors to review filings on the company’s website. CFO Ward was tasked with presenting financial results before Hakim addressed pre-submitted questions, signaling a structured approach to investor communications. The call included standard disclaimers about volatile market conditions, with Elite declining to update projections unless legally required. No breakthrough announcements were made, focusing instead on procedural updates and regulatory compliance.
AI Audio Summary
0:00 / 0:00
Click to play
97f3403c-cafd-4120-938d-c54e631f918d.jpeg
Quantum News · Media Library

SA Transcripts158.48K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call February 18, 2026 11:30 AM EST Company Participants Nasrat Hakim - Chairman, CEO & PresidentCarter Ward - CFO, Secretary & Treasurer Presentation Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Third Quarter of Fiscal Year 2026 Conference Call. [Operator Instructions] Before management begins the conference -- has the following statement. Elite would like to remind the listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties that are subject to change at any time, including, but not limited to, statements about Elite's expectations regarding forward operating results. Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially. Elite disclaims any obligation to update or revise its forward-looking statements, except as required by law. More complete information regarding forward-looking statements, risks, and uncertainties can be found in the reports Elite files with the SEC, which is available on Elite's website at elitepharma.com, under the Investor Relations section. Elite encourages you to review these documents carefully. With that covered, it is now my pleasure to turn the floor over to your host, Mr. Nasrat Hakim, President and Chief Executive Officer of Elite Pharmaceuticals. Sir, the floor is yours. Nasrat HakimChairman, CEO & President Thank you, Matthew, and good morning, ladies and gentlemen, and thank you for joining us today. My name is Nasrat Hakim. I am Elite's Chairman and CEO. This is our earnings call. Our CFO, Carter Ward, will give you a summary of the company's financials, after which I'll give you an update and answer some of the questions that you've submitted to Dianne. Mr. Ward, you have the floor. Carter WardCFO, Secretary & Treasurer

Read Original

Tags

drug-discovery

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.